Safety of subcutaneous immunotherapy with inhalant allergen extracts: a single-center 30-year experience from Turkey

---

Kartal O., Gulec M., Caliskaner Z., Musabak U., Sener O.

IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY, vol.37, no.3, pp.280-286, 2015 (SCI-Expanded)

• Publication Type: Article / Article
• Volume: 37 Issue: 3
• Publication Date: 2015
• Doi Number: 10.3109/08923973.2015.1027918
• Journal Name: IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY
• Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
• Page Numbers: pp.280-286
• Hacettepe University Affiliated: No

Abstract

Context: Although subcutaneous allergen immunotherapy (SCIT) is effective in allergic rhinitis (AR) and asthma, it carries a risk of local and systemic adverse reactions.